Kumral Emre, Evyapan Dilek, Aksu Kenan, Keser Gökhan, Kabasakal Yasemin, Balkir Kaan
Department of Neurology, Ege University Faculty of Medicine, Izmir, Turkey.
Stroke. 2002 Mar;33(3):712-6. doi: 10.1161/hs0302.104167.
Takayasu's arteritis (TA) is a chronic inflammatory disease of unknown etiology that can affect the aorta and its branches. The cerebral ischemia in TA can be caused by a variety of mechanisms, and the focus of this study is to detect the possible contribution of microembolus in the pathogenesis of stroke.
Eighteen patients with TA according to the criteria for the classification of TA of the American College of Rheumatology and 100 age-matched healthy controls were studied. Both middle cerebral arteries were monitored by transcranial Doppler (TCD) ultrasound for at least 30 minutes. All patients with TA were followed up for a mean duration of 2.1 months, and recurrent strokes were registered.
Microembolic signals (MES) were present in 22% of the patients overall, and the intensity of the MES varied between 9 and 30 dB. Moreover, MES were found in 30% of the patients with higher erythrocyte sedimentation rate. Two (67%) of 3 patients who did not receive any treatment had MES, but only 2 (13%) of 15 patients who received immunosuppressive and anticoagulant therapy before the TCD ultrasonography monitoring had MES. During the follow-up period after MES recording, we did not observe any recurrent stroke.
TCD ultrasonography monitoring can be used as an additional noninvasive procedure to detect microembolus in patients with TA during the acute and chronic phase of the disease. The monitoring of MES may also help in choosing better treatment for the long-term prophylaxis of the disease from acute ischemic stroke, but further large studies are required to justify the efficacy of immunosuppressive treatment in these patients.
大动脉炎(TA)是一种病因不明的慢性炎症性疾病,可累及主动脉及其分支。TA中的脑缺血可由多种机制引起,本研究的重点是检测微栓子在中风发病机制中的可能作用。
根据美国风湿病学会TA分类标准,对18例TA患者和100例年龄匹配的健康对照进行研究。通过经颅多普勒(TCD)超声对双侧大脑中动脉进行至少30分钟的监测。所有TA患者平均随访2.1个月,并记录复发性中风情况。
总体上,22%的患者存在微栓子信号(MES),MES强度在9至30分贝之间变化。此外,红细胞沉降率较高的患者中30%存在MES。3例未接受任何治疗的患者中有2例(67%)存在MES,但在TCD超声监测前接受免疫抑制和抗凝治疗的15例患者中只有2例(13%)存在MES。在记录MES后的随访期间,我们未观察到任何复发性中风。
TCD超声监测可作为一种额外的非侵入性检查方法,用于在TA患者疾病的急性期和慢性期检测微栓子。对MES的监测也可能有助于为预防该疾病急性缺血性中风选择更好的长期治疗方法,但需要进一步的大型研究来证实免疫抑制治疗在这些患者中的疗效。